![discount label](https://static.cymitquimica.com/public/img/discount.png)
N-[2-[4-(Aminosulfonyl)-phenyl]-ethyl]-5-methyl-2-pyrazinecarboxamide
CAS: 33288-71-0
Rif. 3D-FA150607
1g | 991,00 € | ||
50mg | 136,00 € | ||
100mg | 190,00 € | ||
250mg | 396,00 € | ||
500mg | 687,00 € |
Informazioni sul prodotto
- 2-pyrazinecarboxamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-methyl-
- 4-[2-(5-Methyl-2-pyrazine carboxamido)ethyl]benzene sulfonamide
- 4-[2-(5-Methylpyrazine-2-carboxamido)ethyl]benzenesulfonamide
- 4-[2-(5-Methylpyrazinyl-2-carboxamido)ethyl]benzenesulfonamide
- 5-Methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
- N-[2-[4-(Aminosulfonyl)phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide
- Pyrazinecarboxamide, 5-methyl-N-(p-sulfamoylphenethyl)-
- Pyrazinecarboxamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-methyl-
Fluoxetine is a potent inhibitor of the enzyme cytochrome P450 (CYP) 2C19. The inhibition of CYP2C19 by fluoxetine may lead to an increase in the plasma concentration of other drugs that are metabolized by this enzyme, such as glipizide and hydroxycyclohexyl. Fluoxetine inhibits human uric acid secretion and increases plasma concentrations of uric acid. This drug also inhibits human erythrocyte dihydropyrimidine dehydrogenase, leading to increased blood levels of pyrimidines, especially cytotoxic ones like 6-fluoro-3-indoxyl-beta-D-galactopyranoside. Fluoxetine has been shown to have a protective effect against acetaminophen toxicity in rats because it enhances the conversion of acetaminophen to its less toxic metabolite N-acetylcysteine.
Proprietà chimiche
Richiesta tecnica su: 3D-FA150607 N-[2-[4-(Aminosulfonyl)-phenyl]-ethyl]-5-methyl-2-pyrazinecarboxamide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.